NY-MEDIAOCEAN
6.3.2024 10:01:33 CET | Business Wire | Press release
Mediaocean, the mission-critical platform for omnichannel advertising, today announced six new partnerships for its Creative Ad Tech platform, Flashtalking, bringing its market leading solutions to more customers in a range of key markets around the world. The agreements provision for primary ad serving, creative personalization, cross-channel measurement and verification across open web display, mobile, audio, video, digital out-of-home, and connected TV.
Collectively, the new activation partners support advertisers in 89 different countries, significantly expanding Flashtalking’s footprint following a surge in adoption after the announcement that Amazon was deprecating its Sizmek ad server. Each of these companies brings deep experience in the ad serving market, having previously supported brands and agencies using Amazon/Sizmek.
Founded in 2001 and acquired by Mediaocean in 2021, Flashtalking is the leading independent ad tech platform, bridging creative and media teams with intelligent, audience-aware insights and workflows at scale and across channels. The Flashtalking platform provides AI and automation to connect the silos between teams for more efficient production, versioning, and distribution of creative.
The new partners include Tailwind, which operates in 36 markets across Central and South Eastern Europe, the Nordics and Middle East North Africa (MENA), empowering businesses to fast track their marketing with technology integrations, strategic consultation, and professional services, as well as Box Digital, a South Africa-based digital advertising services business with customers spanning 8 sub-Saharan African countries.
A partnership with Adsmovil will bolster Flashtalking’s operations within 33 markets across Latin America (LATAM), through a business uniquely focused on Hispanic and Brazilian audiences which currently serves over 4 billion impressions per month. Meanwhile, a new relationship with Adsonice, will grow Flashtalking’s presence across Europe.
Additionally, an agreement with Escape Velocity, a digital media technology services company that supports agencies and advertisers, will scale Flashtalking in India, Korea, Bangladesh, and Sri Lanka while eTechSol will help serve customers in Pakistan.
Simon Thorne, MD EMEA for Flashtalking, commented: “We’ve seen huge appetite for a truly intelligent, dynamic approach to managing and activating creative campaigns. Advertisers need to enable deep personalization, ensuring the most relevant and impactful brand messages reach the right consumers at the right moment, and they want to do it via a single integrated platform. Today’s announcement really cements our position as being the best solution to deliver that on a global level.”
Coming in the wake of Amazon’s announcement that it will be shuttering its ad serving service, these new partnerships represented a unique opportunity to combine Flashtalking’s best-in-class advertising technology with in-market experts who can offer deep local insights and a highly mature ad serving knowledge base.
Flashtalking was recently named a winner of G2 2024 Best Software Awards for Marketing & Digital Advertising Products based on 300+ authenticated customer reviews. The platform was ranked a leader in Enterprise Creative Management Platforms, Cross-Channel, Video, Mobile, Display, and Social Media Advertising.
Georgia Brammer, MD JAPAC for Flashtalking, added, “We’re thrilled to be able to build these new relationships in so many important markets. We’ve been impressed by the drive and knowledge represented by the teams at all of these businesses. This is, on multiple fronts, a time of change in the global advertising sector and, from conversations with major advertisers, the growth potential we’re seeing in further developing this global network is already proving to be really powerful.”
Odysseas Ntotsikas, Managing Partner of Tailwind, stated, “True to Tailwind’s mission to ‘Drive business fast forward’ the power of creative has proved to be the variable with the biggest impact in an omnichannel marketer’s stack. Through this strategic partnership with global leader Flashtalking, we fortify over a decade of operational excellence in empowering hundreds of regional marketers with creative personalization and digital advertising intelligence to win the only war that matters today, the war for attention.”
Alberto Pardo, Founder & CEO of Adsmovil, said, “We, at Adsmovil, have been committed to driving relevance and value to our clients since our inception. Flashtalking furthers our mission and expands the opportunity to better serve clients with personalization based on real-time variables, driving greater congruence and resonance, and a higher advertiser ROI. We are very excited about our partnership.”
Raghu Seelamsetty, MD of Escape Velocity, added, “Escape is delighted to be partnering with Flashtalking. The partnership is well poised to take advantage of the growth of CTV and social media in these fast growing markets. Flashtalking’s market leading technology combined with Escape’s market reach and service capabilities will enable us to deliver world class solutions to our clients.”
About Flashtalking by Mediaocean
Flashtalking unleashes the power of creative to make media work better. As the leading independent platform for personalization and intelligence across all marketing channels, our Creative Ad Tech bridges the gap between creative and media. We provide AI and automation to connect the silos between teams and deliver more efficient production, versioning, and distribution of creative. Our solutions operate at scale across CTV, Video, Display, Social, Native, Audio, DOOH, and Retail Media channels. As part of Mediaocean, Flashtalking is tied into the industry’s core ad infrastructure for omnichannel planning, buying, and billing. Visit flashtalking.com to learn more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240305248528/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
